Zevra Therapeutics, Inc.
ZVRA
$8.33
-$0.06-0.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 199.51M | 202.61M | 62.63M | 69.50M | 89.38M |
| Total Receivables | 16.84M | 18.27M | 12.62M | 10.51M | 7.79M |
| Inventory | 1.37M | 1.11M | 2.56M | 1.97M | -- |
| Prepaid Expenses | 7.40M | 4.35M | 3.77M | 4.05M | 2.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 225.12M | 226.34M | 81.57M | 86.03M | 99.44M |
|
|
|||||
| Total Current Assets | 225.12M | 226.34M | 81.57M | 86.03M | 99.44M |
| Net Property, Plant & Equipment | 1.83M | 2.10M | 2.06M | 1.01M | 1.43M |
| Long-term Investments | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
| Goodwill | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
| Total Other Intangibles | 6.74M | 7.05M | 67.38M | 68.99M | 70.61M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 873.00K | 1.00M | 10.91M | 11.38M | 9.27M |
| Total Assets | 270.12M | 256.28M | 172.71M | 178.13M | 191.55M |
|
|
|||||
| Total Accounts Payable | 11.07M | 15.84M | 17.82M | 13.08M | 24.46M |
| Total Accrued Expenses | 5.61M | 5.60M | 5.17M | 17.37M | 8.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 441.00K | 525.00K | 589.00K | 420.00K | 540.00K |
| Total Finance Division Other Current Liabilities | 8.99M | 6.87M | 3.40M | 3.20M | 930.00K |
| Total Other Current Liabilities | 8.99M | 6.87M | 3.40M | 3.20M | 930.00K |
| Total Current Liabilities | 26.11M | 28.83M | 26.98M | 34.07M | 34.48M |
|
|
|||||
| Total Current Liabilities | 26.11M | 28.83M | 26.98M | 34.07M | 34.48M |
| Long-Term Debt | 61.31M | 60.69M | 60.09M | 59.50M | 58.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 966.00K | 1.06M | 1.16M | 372.00K | 483.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.56M | 48.46M | 43.46M | 44.52M | 27.91M |
| Total Liabilities | 136.95M | 139.05M | 131.69M | 138.46M | 121.78M |
|
|
|||||
| Common Stock & APIC | 580.79M | 564.32M | 560.48M | 555.31M | 550.42M |
| Retained Earnings | -434.23M | -433.68M | -508.39M | -505.29M | -469.55M |
| Treasury Stock & Other | -13.40M | -13.41M | -11.07M | -10.35M | -11.10M |
| Total Common Equity | 133.17M | 117.23M | 41.02M | 39.67M | 69.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 133.17M | 117.23M | 41.02M | 39.67M | 69.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 133.17M | 117.23M | 41.02M | 39.67M | 69.77M |
|
|
|||||